Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 574

1.

Inadvertent consequences of percutaneous coronary intervention to treat unstable spontaneous coronary artery dissection.

Taguchi E, Nakao K, Kogure T, Suzuyama H, Inoue M, Kodama K, Yoshida M, Miyamoto S, Sakamoto T.

J Cardiol Cases. 2015 Jun 6;12(3):74-78. doi: 10.1016/j.jccase.2015.05.004. eCollection 2015 Sep.

PMID:
30524544
2.

Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry.

Wlodarczak A, Lanocha M, Jastrzebski A, Pecherzewski M, Szudrowicz M, Jastrzebski W, Nawrot J, Lesiak M.

Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28036. [Epub ahead of print]

PMID:
30537203
3.

Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial.

Chen S, Redfors B, Liu Y, Vrolix M, Macaya C, Ben-Yehuda O, Kappetein AP, Sabik JF, Serruys PW, Stone GW.

Coron Artery Dis. 2018 Dec 10. doi: 10.1097/MCA.0000000000000688. [Epub ahead of print]

PMID:
30531253
4.

To revascularize or not before transcatheter aortic valve implantation?

Perez S, Thielhelm TP, Cohen MG.

J Thorac Dis. 2018 Nov;10(Suppl 30):S3578-S3587. doi: 10.21037/jtd.2018.09.85. Review.

5.

The Prognostic Value and Clinical Use of Myocardial Perfusion Scintigraphy in Asymptomatic Patients after Percutaneous Coronary Intervention.

Andrade LF, Souza AC, Peclat T, Bartholo C, Pavanelo T, Lima RSL.

Arq Bras Cardiol. 2018 Dec;111(6):784-793. doi: 10.5935/abc.20180199. English, Portuguese.

6.

[ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].

Neumann FJ, Hochholzer W, Siepe M.

Herz. 2018 Dec;43(8):689-694. doi: 10.1007/s00059-018-4764-5. Review. German.

PMID:
30456630
7.

Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.

Uskela S, Kärkkäinen JM, Eränen J, Siljander A, Mäntylä P, Mustonen J, Rissanen TT.

Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950. [Epub ahead of print]

PMID:
30380186
8.

Percutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases.

Flores-Umanzor E, Martin-Yuste V, Caldentey G, Vazquez S, Jimenez-Britez G, San Antonio R, Cepas-Guillen P, Pujol-Lopez M, Hernández M, Sabaté M.

Rev Port Cardiol. 2018 Oct;37(10):865.e1-865.e4. doi: 10.1016/j.repc.2017.03.015. Epub 2018 Oct 21. English, Portuguese.

9.

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention.

Kandzari DE, Gershlick AH, Serruys PW, Leon MB, Morice MC, Simonton CA, Lembo NJ, Banning AP, Merkely B, van Boven AJ, Ungi I, Kappetein AP, Sabik JF 3rd, Généreux P, Dressler O, Stone GW.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007007. doi: 10.1161/CIRCINTERVENTIONS.118.007007.

PMID:
30354633
10.

Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate.

Golino M, Spera FR, Manfredonia L, De Vita A, Di Franco A, Lamendola P, Villano A, Melita V, Mencarelli E, Lanza GA, Crea F.

Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6545-6550. doi: 10.26355/eurrev_201810_16070.

11.

Retrospective Comparison of Long-Term Clinical Outcomes Between Percutaneous Coronary Intervention and Medical Therapy in Stable Coronary Artery Disease With Gray Zone Fractional Flow Reserve - COMFORTABLE Retrospective Study.

Kubo T, Takahata M, Terada K, Mori K, Arita Y, Ino Y, Matsuo Y, Kitabata H, Shiono Y, Shimamura K, Kameyama T, Emori H, Katayama Y, Tanimoto T, Akasaka T.

Circ J. 2018 Nov 24;82(12):3044-3051. doi: 10.1253/circj.CJ-18-0672. Epub 2018 Oct 13.

12.

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial.

Stone GW, Généreux P, Harrington RA, White HD, Gibson CM, Steg PG, Hamm CW, Mahaffey KW, Price MJ, Prats J, Deliargyris EN, Bhatt DL.

Eur Heart J. 2018 Dec 7;39(46):4112-4121. doi: 10.1093/eurheartj/ehy562.

13.

Cardiac magnetic resonance for ischaemia and viability detection. Guiding patient selection to revascularization in coronary chronic total occlusions: The CARISMA_CTO study design.

Pica S, Di Giovine G, Bollati M, Testa L, Bedogni F, Camporeale A, Pontone G, Andreini D, Monti L, Gasparini G, Grancini L, Secco GG, Maestroni A, Ambrogi F, Milani V, Lombardi M.

Int J Cardiol. 2018 Dec 1;272:356-362. doi: 10.1016/j.ijcard.2018.08.061. Epub 2018 Aug 22.

PMID:
30173921
14.

Effect of elective percutaneous coronary intervention of left anterior descending coronary artery on regional myocardial function using strain imaging.

Magdy G, Sadaka M, Elzawawy T, Elmaghraby A.

Egypt Heart J. 2018 Jun;70(2):83-88. doi: 10.1016/j.ehj.2017.12.003. Epub 2017 Dec 24.

15.

Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease.

Cook CM, Ahmad Y, Howard JP, Shun-Shin MJ, Sethi A, Clesham GJ, Tang KH, Nijjer SS, Kelly PA, Davies JR, Malik IS, Kaprielian R, Mikhail G, Petraco R, Al-Janabi F, Karamasis GV, Mohdnazri S, Gamma R, Al-Lamee R, Keeble TR, Mayet J, Sen S, Francis DP, Davies JE.

J Am Coll Cardiol. 2018 Aug 28;72(9):970-983. doi: 10.1016/j.jacc.2018.06.033.

16.
17.
18.

Very Early Versus Early Percutaneous Coronary Intervention After Successful Fibrinolytic Therapy in Pharmacoinvasive Strategy.

Khalfallah M, Elsheikh A, Abdalaal M.

Glob Heart. 2018 Dec;13(4):261-265. doi: 10.1016/j.gheart.2018.06.003. Epub 2018 Aug 8.

PMID:
30098929
19.

Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia.

Choi KH, Lee JM, Park I, Kim J, Rhee TM, Hwang D, Park J, Park TK, Yang JH, Song YB, Hahn JY, Jeong DS, Cho YH, Kim WS, Sung K, Jang MJ, Sung JD, Choi JH, Choi SH, Koo BK, Lee YT, Kim EK, Chang SA, Park SJ, Choi JO, Lee SC, Park SW, Cho YS, Choi JY, Gwon HC, Oh JK.

Int J Cardiol. 2018 Aug 3. pii: S0167-5273(18)32829-8. doi: 10.1016/j.ijcard.2018.08.006. [Epub ahead of print]

PMID:
30093138
20.

Sodium Nitrite-Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis.

Jones DA, Whittaker P, Rathod KS, Richards AJ, Andiapen M, Antoniou S, Mathur A, Ahluwalia A.

J Cardiovasc Pharmacol Ther. 2018 Aug 6:1074248418784940. doi: 10.1177/1074248418784940. [Epub ahead of print]

PMID:
30081658

Supplemental Content

Loading ...
Support Center